Table 2

 Biochemical surfactant properties and gas exchange in healthy controls and patients with acute respiratory distress syndrome (ARDS) receiving either standard care or additional surfactant treatment

ControlARDS
BaselineStandard careSurfactant treatment
+48 h+120 h+48 h+120 h
Data are presented as median (25–75th percentile).
LA, large surfactant aggregate fraction; PL, phospholipids; PC, phosphatidylcholine; PG, phosphatidylglycerol; SP-C, surfactant protein C; Pao2/Fio2, arterial oxygen tension/fractional oxygen inspiration.
Data are given for healthy controls and for patients with ARDS before (baseline; −3 h), 48 h and 120 h after intrabronchial administration of recombinant SP-C-based surfactant (n = 14) and for patients with ARDS receiving standard care only (n = 17). Biochemical data are given for the total lavage fluid. The baseline Pao2/Fio2 value represents the mean of three readings over the 6 h baseline period.
*p<0.05; **p<0.01; ***p<0.001 pre-treatment vs post-treatment.
LA (% of PL)79.1 (70.5–86.5)45.4 (28.8–53.2)27.4 (23.2–52.2)30.5 (25.8–31.10)73.5 (68.3–77.2)**64.2 (55.3–75.2)
PL (µg/ml)23.5 (17.2–29.8)25.6 (14.5–44.6)30.4 (15.2–42.1)17.0 (9.6–25.4)185.0 (44.8–230.0)**48.4 (31.6–78.1)
PC (% of total PL)80.0 (79.0–82.3)77.9 (70.3–81.6)81.1 (73.2–83.1)81.9 (80.6–85.3)77.6 (68.1–83.5)72.9 (66.6–78.1)
PG (% of total PL)11.8 (11.3–12.7)1.6 (1.2–2.6)1.9 (0.7–5.5)2.1 (0.8–2.3)15.7 (8.9–21.8)**6.8 (5.3–13.7)*
Palmitic acid (% of PC fatty acids)74.2 (71.4–77.1)53.6 (44.8–59.2)52.6 (50.3–57.4)57.8 (56.3–59.2)85.6 (77.8–89.4)**84.1 (78.5–84.2)**
SP-C (ng/ml)494.9 (397.0–601.0)350.2 (216.4–724.3)437.0 (250.0–657.0)436.0 (284.0–760.0)1970.0 (770.0–2490.0)**717.0 (290.0–1160.0)
Pao2/Fio2 (mm Hg)461.0 (446.0–469.0)126.5 (103–149.7)134.0 (94.1–164.0)156.0 (85.0–215.0)143.0 (138.0–182.0)**212.0 (156.0–250.0)***